A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm

{ 'indexed': {'date-parts': [[2023, 1, 14]], 'date-time': '2023-01-14T10:55:04Z', 'timestamp': 1673693704195}, 'reference-count': 40, 'publisher': 'Springer Science and Business Media LLC', 'issue': '8', 'license': [ { 'start': { 'date-parts': [[2021, 4, 10]], 'date-time': '2021-04-10T00:00:00Z', 'timestamp': 1618012800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}, { 'start': { 'date-parts': [[2021, 4, 10]], 'date-time': '2021-04-10T00:00:00Z', 'timestamp': 1618012800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}], 'funder': [ { 'DOI': '10.13039/501100005001', 'name': 'Ahvaz Jundishapur University of Medical Sciences', 'doi-asserted-by': 'publisher', 'award': ['IR.AJUMS.REC.1399.003']}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021, 11]]}, 'DOI': '10.1007/s11739-021-02734-8', 'type': 'journal-article', 'created': {'date-parts': [[2021, 4, 10]], 'date-time': '2021-04-10T14:02:41Z', 'timestamp': 1618063361000}, 'page': '2181-2191', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 32, 'title': 'A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on ' 'COVID-19-related cytokine storm', 'prefix': '10.1007', 'volume': '16', 'author': [ {'given': 'Mandana', 'family': 'Pouladzadeh', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-9735-2632', 'authenticated-orcid': False, 'given': 'Mehdi', 'family': 'Safdarian', 'sequence': 'additional', 'affiliation': []}, {'given': 'Peyman', 'family': 'Eshghi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hassan', 'family': 'Abolghasemi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alireza Ghorbani', 'family': 'bavani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Behnam', 'family': 'Sheibani', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-6362-7842', 'authenticated-orcid': False, 'given': 'Parastoo', 'family': 'Moradi Choghakabodi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Abdolaziz', 'family': 'Feghhi', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Mehri', 'family': 'Ghafourian Boroujerdnia', 'sequence': 'additional', 'affiliation': []}, {'given': 'Arash', 'family': 'Forouzan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohammad Ali', 'family': 'Jalali Far', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gholam Abbas', 'family': 'Kaydani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elham', 'family': 'Rajaei', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mansour', 'family': 'Amin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mehdi', 'family': 'Torabizadeh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Farid', 'family': 'Yousefi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Reza', 'family': 'Hadaddezfuli', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2021, 4, 10]]}, 'reference': [ { 'key': '2734_CR1', 'doi-asserted-by': 'publisher', 'first-page': '497', 'DOI': '10.1016/S0140-6736(20)30183-5', 'volume': '395', 'author': 'C Huang', 'year': '2020', 'unstructured': 'Huang C, Wang Y, Li X et al (2020) Clinical features of patients ' 'infected with 2019 novel coronavirus in Wuhan China. Lancet 395:497–506', 'journal-title': 'Lancet'}, { 'issue': '1', 'key': '2734_CR2', 'doi-asserted-by': 'publisher', 'first-page': '1123', 'DOI': '10.1080/22221751.2020.1770129', 'volume': '9', 'author': 'H Han', 'year': '2020', 'unstructured': 'Han H, Ma Q, Li C et al (2020) Profiling serum cytokines in COVID-19 ' 'patients reveals IL-6 and IL-10 are disease severity predictors. Emerg ' 'Microbes Infect 9(1):1123–1130', 'journal-title': 'Emerg Microbes Infect'}, { 'key': '2734_CR3', 'first-page': 'E005', 'volume': '43', 'author': 'L Chen', 'year': '2020', 'unstructured': 'Chen L, Liu HG, Liu W et al (2020) Analysis of clinical features of 29 ' 'patients with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi ' 'Za Zhi 43:E005', 'journal-title': 'Zhonghua Jie He He Hu Xi Za Zhi'}, { 'key': '2734_CR4', 'doi-asserted-by': 'publisher', 'author': 'Z Xu', 'year': '2020', 'unstructured': 'Xu Z, Shi L, Wang Y et al (2020) Pathological findings of COVID-19 ' 'associated with acute respiratory distress syndrome. Lancet Respir Med. ' 'https://doi.org/10.1016/S2213-2600(20)30076-X', 'journal-title': 'Lancet Respir Med', 'DOI': '10.1016/S2213-2600(20)30076-X'}, { 'key': '2734_CR5', 'doi-asserted-by': 'publisher', 'first-page': '529', 'DOI': '10.1007/s00281-017-0629-x', 'volume': '39', 'author': 'R Channappanavar', 'year': '2017', 'unstructured': 'Channappanavar R, Perlman S (2017) Pathogenic human coronavirus ' 'infections: causes and consequences of cytokine storm and ' 'immunopathology. Semin Immunopathol 39:529–539', 'journal-title': 'Semin Immunopathol'}, { 'issue': '15', 'key': '2734_CR6', 'doi-asserted-by': 'publisher', 'first-page': '769', 'DOI': '10.1093/cid/ciaa272', 'volume': '71', 'author': 'Z Wang', 'year': '2020', 'unstructured': 'Wang Z, Yang B, Li Q et al (2020) Clinical features of 69 cases with ' 'coronavirus disease 2019 in Wuhan, China. Clin Infect Dis 71(15):769–777', 'journal-title': 'Clin Infect Dis'}, { 'key': '2734_CR7', 'doi-asserted-by': 'publisher', 'first-page': '2620', 'DOI': '10.1172/JCI137244', 'volume': '130', 'author': 'G Chen', 'year': '2020', 'unstructured': 'Chen G, Wu D, Guo W et al (2020) Clinical and immunological features of ' 'severe and moderate coronavirus disease 2019. J Clin Invest ' '130:2620–2629', 'journal-title': 'J Clin Invest'}, { 'key': '2734_CR8', 'doi-asserted-by': 'publisher', 'first-page': '961', 'DOI': '10.1016/j.annonc.2020.03.300', 'volume': '31', 'author': 'JM Michot', 'year': '2020', 'unstructured': 'Michot JM, Albiges L, Chaput N et al (2020) Tocilizumab, an anti-IL6 ' 'receptor antibody, to treat Covid-19-related respiratory failure: a case ' 'report. Ann Oncol 31:961–964', 'journal-title': 'Ann Oncol'}, { 'key': '2734_CR9', 'doi-asserted-by': 'publisher', 'first-page': '1307', 'DOI': '10.1182/bloodadvances.2020001907', 'volume': '4', 'author': 'X Zhang', 'year': '2020', 'unstructured': 'Zhang X, Song K, Tong F et al (2020) First case of COVID-19 in a patient ' 'with multiple myeloma successfully treated with tocilizumab. Blood Adv ' '4:1307–1310', 'journal-title': 'Blood Adv'}, { 'key': '2734_CR10', 'doi-asserted-by': 'publisher', 'author': 'MH Odievre', 'year': '2020', 'unstructured': 'Odievre MH, de Marcellus C, Le Ducou Pointe H et al (2020) Dramatic ' 'improvement after tocilizumab of a severe COVID-19 in a child with ' 'sickle cell disease and acute chest syndrome. Am J Hematol. ' 'https://doi.org/10.1002/ajh.25855', 'journal-title': 'Am J Hematol.', 'DOI': '10.1002/ajh.25855'}, { 'key': '2734_CR11', 'doi-asserted-by': 'publisher', 'first-page': '507', 'DOI': '10.1016/S0140-6736(20)30211-7', 'volume': '395', 'author': 'N Chen', 'year': '2020', 'unstructured': 'Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical ' 'characteristics of 99 cases of 2019 novel coronavirus pneumonia in ' 'Wuhan, China: a descriptive study. Lancet 395:507–513', 'journal-title': 'Lancet'}, { 'key': '2734_CR12', 'doi-asserted-by': 'publisher', 'first-page': '1061', 'DOI': '10.1001/jama.2020.1585', 'volume': '323', 'author': 'D Wang', 'year': '2020', 'unstructured': 'Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 ' 'hospitalized patients with 2019 novel coronavirus-infected pneumonia in ' 'Wuhan China. JAMA 323:1061–1069', 'journal-title': 'JAMA'}, { 'key': '2734_CR13', 'doi-asserted-by': 'publisher', 'first-page': 'm1335', 'DOI': '10.1136/bmj.m1335', 'volume': '369', 'author': 'J Lenzer', 'year': '2020', 'unstructured': 'Lenzer J (2020) Covid-19: US gives emergency approval to ' 'hydroxychloroquine despite lack of evidence. BMJ 369:m1335', 'journal-title': 'BMJ'}, { 'key': '2734_CR14', 'unstructured': 'World Health Organization. Coronavirus Disease 2019(COVID-19) Situation ' 'Report-41: Data as Reported by 10AM CET 01 March 2020. Available online ' 'at: ' 'https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200301-sitrep-41-covid-19.pdf?sfvrsn=6768306d_2.'}, { 'key': '2734_CR15', 'doi-asserted-by': 'publisher', 'first-page': '1708', 'DOI': '10.3389/fimmu.2020.01708', 'volume': '11', 'author': 'Y Tang', 'year': '2020', 'unstructured': 'Tang Y, Liu J, Zhang D et al (2020) Cytokine storm in COVID-19: the ' 'current evidence and treatment strategies. Front Immunol 11:1708', 'journal-title': 'Front Immunol'}, { 'key': '2734_CR16', 'doi-asserted-by': 'publisher', 'first-page': '435', 'DOI': '10.1186/s13054-020-03130-y', 'volume': '24', 'author': 'M Rieder', 'year': '2020', 'unstructured': 'Rieder M, Wengenmayer T, Staudacher D et al (2020) Cytokine adsorption ' 'in patients with severe COVID-19 pneumonia requiring extracorporeal ' 'membrane oxygenation. Crit Care 24:435. ' 'https://doi.org/10.1186/s13054-020-03130-y', 'journal-title': 'Crit Care'}, { 'key': '2734_CR17', 'first-page': '281', 'volume': '40', 'author': 'W Tan', 'year': '2020', 'unstructured': 'Tan W, Li S, Yiyang C et al (2020) Clinical efficacy analysis of 50 ' 'cases of corona virus disease 2019 in traditional Chinese medicine. ' 'Jilin J Chin Med 40:281–285', 'journal-title': 'Jilin J Chin Med'}, { 'key': '2734_CR18', 'first-page': '8', 'volume': '26', 'author': 'Y Kai-tao', 'year': '2020', 'unstructured': 'Kai-tao Y, Ming-yu L, Xin L et al (2020) Retrospective clinical analysis ' 'on treatment of novel coronavirus-infected pneumonia with traditional ' 'Chinese medicine Lianhua Qingwen. Chin J Exp Tradition Med Formul ' '26:8–12', 'journal-title': 'Chin J Exp Tradition Med Formul'}, { 'key': '2734_CR19', 'doi-asserted-by': 'publisher', 'first-page': '123', 'DOI': '10.1016/j.pharmthera.2016.07.002', 'volume': '166', 'author': 'L Hou', 'year': '2016', 'unstructured': 'Hou L, Huang H (2016) Immune suppressive properties of artemisinin ' 'family drugs. Pharmacol Therap 166:123–127', 'journal-title': 'Pharmacol Therap'}, { 'key': '2734_CR20', 'doi-asserted-by': 'publisher', 'first-page': '80', 'DOI': '10.1093/infdis/jiu396', 'volume': '211', 'author': 'J Mair-Jenkins', 'year': '2015', 'unstructured': 'Mair-Jenkins J, Saavedra-Campos M, Baillie JK et al (2015) The ' 'effectiveness of convalescent plasma and hyperimmune immunoglobulin for ' 'the treatment of severe acute respiratory infections of viral etiology: ' 'a systematic review and exploratory meta-analysis. J Infect Dis ' '211:80–90', 'journal-title': 'J Infect Dis'}, { 'key': '2734_CR21', 'doi-asserted-by': 'publisher', 'first-page': '435', 'DOI': '10.1086/519392', 'volume': '196', 'author': 'CB Planitzer', 'year': '2007', 'unstructured': 'Planitzer CB, Modrof J, Kreil TR (2007) West Nile virus neutralization ' 'by US plasma-derived immunoglobulin products. J Infect Dis 196:435–440', 'journal-title': 'J Infect Dis'}, { 'key': '2734_CR22', 'doi-asserted-by': 'publisher', 'first-page': '102375', 'DOI': '10.1016/j.jaut.2019.102375', 'volume': '106', 'author': 'M Rojas', 'year': '2020', 'unstructured': 'Rojas M, Monsalve DM, Pacheco Y et al (2020) Ebola virus disease: An ' 'emerging and re-emerging viral threat. J Autoimmun 106:102375', 'journal-title': 'J Autoimmun'}, { 'key': '2734_CR23', 'doi-asserted-by': 'publisher', 'first-page': '39', 'DOI': '10.1016/j.tracli.2015.12.003', 'volume': '23', 'author': 'O Garraud', 'year': '2016', 'unstructured': 'Garraud O, Heshmati F, Pozzetto B et al (2016) Plasma therapy against ' 'infectious pathogens, as of yesterday, today and tomorrow. Transfus Clin ' 'Biol 23:39–44', 'journal-title': 'Transfus Clin Biol'}, { 'issue': '5', 'key': '2734_CR24', 'doi-asserted-by': 'publisher', 'first-page': '460', 'DOI': '10.1001/jama.2020.10044', 'volume': '324', 'author': 'L Li', 'year': '2020', 'unstructured': 'Li L, Zhang W, Hu Y et al (2020) Effect of convalescent plasma therapy ' 'on time to clinical improvement in patients with severe and ' 'life-threatening COVID-19: a randomized clinical trial. JAMA ' '324(5):460–470', 'journal-title': 'JAMA'}, { 'issue': '5', 'key': '2734_CR25', 'doi-asserted-by': 'publisher', 'first-page': '102875', 'DOI': '10.1016/j.transci.2020.102875', 'volume': '59', 'author': 'H Abolghasemi', 'year': '2020', 'unstructured': 'Abolghasemi H, Eshghi P, Cheraghali AM et al (2020) Clinical efficacy of ' 'convalescent plasma for treatment of COVID-19 infections: results of a ' 'multicenter clinical study. Transfus Apher Sci. 59(5):102875', 'journal-title': 'Transfus Apher Sci.'}, { 'issue': '17', 'key': '2734_CR26', 'doi-asserted-by': 'publisher', 'first-page': '9490', 'DOI': '10.1073/pnas.2004168117', 'volume': '117', 'author': 'K Duan', 'year': '2020', 'unstructured': 'Duan K, Liu B, Li C et al (2020) Effectiveness of convalescent plasma ' 'therapy in severe COVID-19 patients. ProcNatl Acad Sci. ' '117(17):9490–9496', 'journal-title': 'ProcNatl Acad Sci.'}, { 'key': '2734_CR27', 'doi-asserted-by': 'publisher', 'author': 'A Gharbharan', 'year': '2020', 'unstructured': 'Gharbharan A, Jordans CCE, GeurtsvanKessel C et al (2020) Convalescent ' 'plasma for COVID-19. A randomized clinical trial. MedRxiv. ' 'https://doi.org/10.1101/2020.07.01.20139857', 'journal-title': 'MedRxiv.', 'DOI': '10.1101/2020.07.01.20139857'}, { 'issue': '8', 'key': '2734_CR28', 'doi-asserted-by': 'publisher', 'first-page': '1680', 'DOI': '10.1016/j.ajpath.2020.05.014', 'volume': '190', 'author': 'E Salazar', 'year': '2020', 'unstructured': 'Salazar E, Perez KK, Ashraf M et al (2020) Treatment of COVID-19 ' 'patients with convalescent plasma. Am J Pathol 190(8):1680–1690', 'journal-title': 'Am J Pathol'}, { 'issue': '6', 'key': '2734_CR29', 'doi-asserted-by': 'publisher', 'first-page': '759', 'DOI': '10.1182/blood.2020006964', 'volume': '136', 'author': 'L Hegerova', 'year': '2020', 'unstructured': 'Hegerova L, Gooley T, Sweerus KA, Maree CL, Bailey N, Bailey M et al ' '(2020) (2020) Use of convalescent plasma in hospitalized patients with ' 'covid-19—case series. Blood 136(6):759–762', 'journal-title': 'Blood'}, { 'issue': '6', 'key': '2734_CR30', 'doi-asserted-by': 'publisher', 'first-page': '755', 'DOI': '10.1182/blood.2020007079', 'volume': '136', 'author': 'X Xia', 'year': '2020', 'unstructured': 'Xia X, Li K, Wu L et al (2020) Improved clinical symptoms and mortality ' 'on severe/critical COVID-19 patients utilizing convalescent plasma ' 'transfusion. Blood 136(6):755–759', 'journal-title': 'Blood'}, { 'issue': '7', 'key': '2734_CR31', 'first-page': '013600', 'volume': '7', 'author': 'V Piechotta', 'year': '2020', 'unstructured': 'Piechotta V, Chai KL, Valk SJ, Doree C, Monsef I, Wood EM et al (2020) ' 'Convalescent plasma or hyperimmune immunoglobulin for people with ' 'COVID-19: a living systematic review. Cochrane Database Syst Rev. ' '7(7):013600', 'journal-title': 'Cochrane Database Syst Rev.'}, { 'issue': 'Suppl. 1', 'key': '2734_CR32', 'doi-asserted-by': 'publisher', 'first-page': '9S', 'DOI': '10.1111/j.1537-2995.2012.03622.x', 'volume': '52', 'author': 'RJ Benjamin', 'year': '2012', 'unstructured': 'Benjamin RJ, McLaughlin LS (2012) Plasma components: properties, ' 'differences, and uses. Transfusion 52(Suppl. 1):9S-19S', 'journal-title': 'Transfusion'}, { 'key': '2734_CR33', 'doi-asserted-by': 'publisher', 'first-page': '80', 'DOI': '10.1038/nrneurol.2014.253', 'volume': '11', 'author': 'JD Lunemann', 'year': '2015', 'unstructured': 'Lunemann JD, Nimmerjahn F, Dalakas MC (2015) Intravenous immunoglobulin ' 'in neurology–mode of action and clinical efficacy. Nat Rev Neurol ' '11:80–89', 'journal-title': 'Nat Rev Neurol'}, { 'key': '2734_CR34', 'doi-asserted-by': 'publisher', 'author': 'A Agarwal', 'year': '2020', 'unstructured': 'Agarwal A, Mukherjee A, Kumar G, Chatterjee P, Bhatnagar T, Malhotra P ' '(2020) Convalescent plasma in the management of moderate covid-19 in ' 'adults in India: open label phase II multicentre randomised controlled ' 'trial (PLACID Trial). BMJ. https://doi.org/10.1136/bmj.m3939', 'journal-title': 'BMJ', 'DOI': '10.1136/bmj.m3939'}, { 'key': '2734_CR35', 'first-page': 'NEJMoa2031304', 'volume': '24', 'author': 'VA Simonovich', 'year': '2020', 'unstructured': 'Simonovich VA, Burgos Pratx LD, Scibona P, Beruto MV, Vallone MG, ' 'Vázquez C et al (2020) A randomized trial of convalescent plasma in ' 'Covid-19 severe pneumonia. N Engl J Med. 24:NEJMoa2031304', 'journal-title': 'N Engl J Med.'}, { 'issue': '7', 'key': '2734_CR36', 'first-page': '415', 'volume': '111', 'author': 'PM Choghakabodi', 'year': '2020', 'unstructured': 'Choghakabodi PM, Pouladzadeh M, Haybar H et al (2020) Biological ' 'whistleblowers for silent myocardial ischemia: diagnostic and prognostic ' 'approach. Recenti Prog Med 111(7):415–425', 'journal-title': 'Recenti Prog Med'}, { 'issue': '2', 'key': '2734_CR37', 'doi-asserted-by': 'publisher', 'first-page': '464', 'DOI': '10.1378/chest.12-2907', 'volume': '144', 'author': 'IFN Hung', 'year': '2013', 'unstructured': 'Hung IFN, Toe KKW, Lee C-K et al (2013) Hyperimmune IV immunoglobulin ' 'treatment: a multicenter double-blind randomized controlled trial for ' 'patients with severe 2009 influenza A (H1N1) infection. Chest ' '144(2):464–473', 'journal-title': 'Chest'}, { 'issue': '4', 'key': '2734_CR38', 'doi-asserted-by': 'publisher', 'first-page': '447', 'DOI': '10.1093/cid/ciq106', 'volume': '52', 'author': 'IF Hung', 'year': '2011', 'unstructured': 'Hung IF, To KK, Lee C-K et al (2011) Convalescent plasma treatment ' 'reduced mortality in patients with severe pandemic influenza A (H1N1) ' '2009 virus infection. Clin Infect Dis 52(4):447–456', 'journal-title': 'Clin Infect Dis'}, { 'issue': '17', 'key': '2734_CR39', 'doi-asserted-by': 'publisher', 'first-page': 'e38', 'DOI': '10.1056/NEJMc2007575', 'volume': '382', 'author': 'Y Zhang', 'year': '2020', 'unstructured': 'Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W et al (2020) ' 'Coagulopathy and antiphospholipid antibodies in patients with Covid-19. ' 'N Engl J Med 382(17):e38', 'journal-title': 'N Engl J Med'}, { 'key': '2734_CR40', 'doi-asserted-by': 'publisher', 'first-page': '109829', 'DOI': '10.1016/j.mehy.2020.109829', 'volume': '142', 'author': 'G Magro', 'year': '2020', 'unstructured': 'Magro G (2020) Cytokine storm: is it the only major death factor in ' 'COVID-19 patients? Coagul role Med Hypotheses 142:109829', 'journal-title': 'Coagul role Med Hypotheses'}], 'container-title': 'Internal and Emergency Medicine', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s11739-021-02734-8.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s11739-021-02734-8/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s11739-021-02734-8.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 11, 2]], 'date-time': '2021-11-02T07:19:18Z', 'timestamp': 1635837558000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s11739-021-02734-8'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 4, 10]]}, 'references-count': 40, 'journal-issue': {'issue': '8', 'published-print': {'date-parts': [[2021, 11]]}}, 'alternative-id': ['2734'], 'URL': 'http://dx.doi.org/10.1007/s11739-021-02734-8', 'relation': {}, 'ISSN': ['1828-0447', '1970-9366'], 'subject': ['Emergency Medicine', 'Internal Medicine'], 'container-title-short': 'Intern Emerg Med', 'published': {'date-parts': [[2021, 4, 10]]}, 'assertion': [ { 'value': '11 December 2020', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '30 March 2021', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '10 April 2021', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'All the procedures performed in studies involving human participants were in ' 'accordance with the ethical standards of the national research committee and ' 'with the 2008 Helsinki Declaration and its later amendments or comparable ' 'ethical standards. This hospital-based, parallel-group and randomized ' 'controlled trial was approved by the Ethics Committee of Ahvaz Jundishapur ' 'University of Medical Sciences, Ahvaz, Iran with Ethical Code: ' 'IR.AJUMS.REC.1399.003 and IRCT20200310046736N1.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Ethical approval'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}